Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesEffect of High Bolus Dose Tirofiban on the Inflammatory Response Following Percutaneous Coronary Intervention
Clinical Cardiology, 10/21/09
Azar RR et al. – In low–risk patients undergoing PCI, tirofiban did not attenuate the rise of inflammatory markers. However, the significant effect in diabetics suggests that tirofiban may have anti–inflammatory activity in higher risk patients.
Related Articles
Selective endothelin A-receptor blockade attenuates coronary microvascular dysfunction after coronary stenting in patients with type 2 diabetes
Vascular Health and Risk Management, 10/29/09
Relevance Score: 88%
Multiple coronary artery aneurysm formation one year and four years after sirolimus-eluting coronary stent implantation
Cardiovascular Revascularization Medicine, 10/16/09
Relevance Score: 88%
Lack of Association Between the Cholesteryl Ester Transfer Protein Gene--TaqIB Polymorphism and Coronary Restenosis Following Percutaneous Transluminal Coronary Angioplasty and Stenting: A Pilot Study
Angiology, 10/09/09
Relevance Score: 88%
Design and rationale of the Evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) trial
American Heart Journal, 10/06/09
Relevance Score: 88%
Can we improve length of hospitalization in ST elevation myocardial infarction patients treated with primary percutaneous coronary intervention
Canadian Journal of Cardiology, 10/12/09
Relevance Score: 87%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09
Prevalence of Inappropriate Use of Digoxin in 136 Patients on Digoxin and Prevalence of Use of Warfarin or Aspirin in 89 Patients With Persistent or Paroxysmal Atrial Fibrillation
American Journal of Therapeutics, 11/25/09
Efficacy of an Olmesartan Medoxomil–Based Treatment Algorithm in Patients Stratified by Age, Race, or Sex
The Journal of Clinical Hypertension, 11/24/09
Today in Inflammation...keeping you current
Receive free subspecialty "5-minute updates" via email
Relationship Between Baseline Inflammatory Markers, Antiplate let Therapy, and Adverse Cardiac Events After Percutaneous Coronary Intervention
Circulation: Cardiovascular Interventions, 11/24/09
The TIR/BB-loop mimetic AS-1 protects the myocardium from ischaemia/reperfusion injury
Cardiovascular Research, 11/20/09
Spironolactone and Chlorthalidone in Uncontrolled Elderly Hypertensive Patients Treated with Calcium Antagonists and Angiotensin II Receptor-Blocker: Effects on Endothelial Function, Inflammation, and Oxidative Stress
Clinical and Experimental Hypertension, 11/19/09
Today in Interventional...keeping you current
Receive free subspecialty "5-minute updates" via email
Percutaneous Coronary Intervention Outcomes in a Low-Volume Center
Circulation: Cardiovascular Quality and Outcomes, 11/24/09
Outcomes With Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Graft Intervention
JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, 11/24/09
No Association of Chromosome 9p21.3 Variation With Clinical and Angiographic Outcomes After Placement of Drug-Eluting Stents
JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, 11/24/09
Sponsor
Article Search
Sponsor
Sponsor